Peter Reiner is Professor of Neuroethics in the Department of Psychiatry at the University of British Columbia and a member of the Centre for Artificial Intelligence Decision-making and Action.
The author of over 100 peer-reviewed publications including papers in Science, Nature and PNAS, Professor Reiner began his career as a member of the storied Kinsmen Laboratory of Neurological Research at UBC where he was the inaugural holder of the Louise Brown Chair in Neuroscience. He went on to become founder, President and CEO of Active Pass Pharmaceuticals, and in 2007 co-founded the National Core for Neuroethics.
A champion of applying rigorous quantitative methods to neuroethical issues, Professor Reiner is frequently quoted in the media. He has testified before the Presidential Commission for the Study of Bioethical Issues, the Council of Europe/OECD, and the Special Joint Parliamentary Committee on Medical Assistance in Dying. His current research is supported by unrestricted grants-in-aid from Google's Artists + Machine Intelligence program (AI-enhanced songwriting) and from the Survival and Flourishing Fund (A toolkit for detecting technomoral change in response to AI).